
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-06 | LEDOUX MARK A | Director & CEO/Chairman | Purchase | 532 | $2.80 | $1K | 160.2K | View ↗ | |
| 2026-03-05 | 2026-03-06 | LEDOUX MARK A | Director & CEO/Chairman | Purchase | 218 | $2.75 | $599.50 | 159.7K | View ↗ | |
| 2026-03-04 | 2026-03-06 | LEDOUX MARK A | Director & CEO/Chairman | Purchase | 500 | $2.77 | $1K | 159.5K | View ↗ | |
| 2026-03-02 | 2026-03-03 | LEDOUX MARK A | Director & CEO/Chairman | Purchase | 500 | $2.79 | $1K | 159.0K | View ↗ | |
| 2026-02-27 | 2026-03-03 | LEDOUX MARK A | Director & CEO/Chairman | Purchase | 750 | $2.83 | $2K | 158.5K | View ↗ |
No annual data found.
CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
Natural Alternatives: Fiscal Q2 Earnings Snapshot